Clinical Significance of EPCAM Pathogenic Germline Variant
Jun-Ha Jang, R.N., Kyoung-Bo Kim, M.D., Jong Eun Park, M.D., Mi-Ae Jang, M.D., Dongju Won, M.D., Boyoung Park, M.D., Jung-Sook Ha, M.D., Sun-Young Kong, M.D.. Lab Med Online 2025;15:263-76. https://doi.org/10.47429/lmo.2025.15.4.263
Authors
- Mi‐Ae Jang (ORCID: https://orcid.org/0000-0002-6558-5236)
- Dongju Won (ORCID: https://orcid.org/0000-0002-0084-0216)
- Jeong-Ho Jang
- Kyoung Bo Kim (ORCID: https://orcid.org/0000-0001-6461-8852)
- Sun‐Young Kong (ORCID: https://orcid.org/0000-0003-0620-4058)
- Jung‐Sook Ha (ORCID: https://orcid.org/0000-0002-6475-4886)
- Jong Eun Park (ORCID: https://orcid.org/0000-0001-9131-6518)
Institutions
- Yonsei University (KR)
- Samsung Medical Center (KR)
- National Cancer Center (KR)
- Hanyang University Guri Hospital (KR)
- Hanyang University (KR)
- Keimyung University (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Laboratory Medicine Online
- Published
- 2025-09-24
- DOI
- https://doi.org/10.47429/lmo.2025.15.4.263
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00